What question did this study set out to answer?

To investigate the renal hemodynamic effects of sodium-glucose cotransporter 2 inhibition in individuals with type 1 diabetes mellitus.

December 13, 2013Circulation1,325 citationsOpen Access

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

To investigate the renal hemodynamic effects of sodium-glucose cotransporter 2 inhibition in individuals with type 1 diabetes mellitus.
Randomized trial with patients diagnosed with type 1 diabetes
Intervention involved sodium-glucose cotransporter 2 inhibitors
Trial registration identifier NCT01392560.
Sodium-glucose cotransporter 2 inhibition improved renal blood flow measurements.
Significant changes in kidney function markers were observed post-treatment.

http://www.clinicaltrials.gov. Unique identifier: NCT01392560.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper